|
DNAJC9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.1979999999997E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.819960E-03 |
| Normal-vs-Stage2 |
1.396970E-01 |
| Normal-vs-Stage3 |
1.139720E-02 |
| Normal-vs-Stage4 |
3.116300E-02 |
| Stage1-vs-Stage2 |
7.567800E-01 |
| Stage1-vs-Stage3 |
2.687600E-01 |
| Stage1-vs-Stage4 |
2.616800E-01 |
| Stage2-vs-Stage3 |
3.404200E-01 |
| Stage2-vs-Stage4 |
2.474400E-01 |
| Stage3-vs-Stage4 |
7.773800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.558670E-04 |
| Normal-vs-AfricanAmerican |
4.220000E-03 |
| Normal-vs-Asian |
6.188700E-04 |
| Caucasian-vs-AfricanAmerican |
8.292600E-01 |
| Caucasian-vs-Asian |
1.954230E-01 |
| AfricanAmerican-vs-Asian |
1.544600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.417100E-04 |
| Normal-vs-Female |
1.50684999999928E-05 |
| Male-vs-Female |
1.983560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.211900E-02 |
| Normal-vs-Extreme_Weight |
1.958390E-03 |
| Normal-vs-Obese |
6.225900E-04 |
| Normal-vs-Extreme_Obese |
8.729800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.308800E-01 |
| Normal_Weight-vs-Obese |
1.907600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.573780E-01 |
| Extreme_Weight-vs-Obese |
3.527400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.939500E-02 |
| Obese-vs-Extreme_Obese |
5.203600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.33020000000228E-05 |
| Normal-vs-Age(41-60Yrs) |
2.30390000000025E-05 |
| Normal-vs-Age(61-80Yrs) |
2.956500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.344600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.135900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.378300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.780000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.244800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.279600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.724600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.55912999999508E-05 |
| Normal-VS-Type2 PRCC |
7.387600E-01 |
| Normal-VS-KIRP CIMP |
2.785200E-04 |
| Normal-VS-Unclassified PRCC |
1.404090E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.3409999999946E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.29419999997482E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.217400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.06169994807237E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
1.672390E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.90430000000564E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.227600E-01 |
| Normal-vs-N1 |
1.095960E-03 |
| Normal-vs-N2 |
2.933600E-01 |
| N0-vs-N1 |
7.295000E-03 |
| N0-vs-N2 |
3.997200E-01 |
| N1-vs-N2 |
8.551800E-01 |
|
|
